本頁面由Tiger Trade Technology Pte. Ltd.提供服務

10x Genomics, Inc.

65.04
+1.241.94%
成交量:234.20萬
成交額:1.54億
市值:84.74億
市盈率:-110.54
高:66.94
開:64.20
低:62.51
收:63.80
52周最高:66.94
52周最低:11.16
股本:1.30億
流通股本:1.18億
量比:1.00
換手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-0.5884
每股收益(LYR):-0.3490
淨資產收益率:-9.40%
總資產收益率:-5.05%
市淨率:10.26
市盈率(LYR):-186.33

資料載入中...

2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors